IL282953A
(en )
2021-06-30
Agents for treatment of claudin expressing cancer diseases
IL289300A
(en )
2022-02-01
Combination therapy for treating cancer
DK2818482T3
(da )
2019-07-15
Farmaceutisk sammensætning til behandling af cancer
DK2824114T3
(da )
2019-07-29
Farmaceutisk sammensætning til behandling af cancer
LT3470063T
(lt )
2025-02-10
Farmacinės kompozicijos, skirtos cftr nulemtų ligų gydymui
IL238565B
(en )
2022-05-01
Treatment of cancers using pi3 kinase isoform modulators
DK3181128T3
(da )
2023-06-06
Farmaceutisk nilotinib-sammensætning
DK2818481T3
(da )
2019-10-14
Farmaceutisk sammensætning til behandling og/eller forebyggelse af cancer
CL2014003165A1
(es )
2015-03-20
Proceso mejorado para la preparación de treprostinil y derivados del mismo.
IL240976A0
(en )
2015-11-30
A pharmaceutical preparation containing albumin-binding arginine deaminase for targeted cancer therapy
DK2897594T3
(da )
2020-06-29
Farmaceutisk sammensætning
LT2914254T
(lt )
2020-04-27
Kombinacinės terapijos chemoresistencinių vėžių gydymui
EP3062790A4
(en )
2017-05-24
Pharmaceutical combinations for the treatment of cancer
HRP20190050T1
(hr )
2019-03-08
Farmaceutski pripravci za kombinacijsku terapiju
HUE045947T2
(hu )
2020-02-28
Formuláció IBS kezelésére
DK2802351T3
(da )
2019-05-13
Midler til behandling af triple-negativ brystkræft
BR112015012877A2
(pt )
2018-04-24
composto de fórmula, composição farmacêutica, uso do composto e método para o tratamento do câncer
IL237146A0
(en )
2015-04-30
Pharmaceutical compound containing Rabamipide
EP2823825A4
(en )
2015-10-14
PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT
EP3020399A4
(en )
2016-12-28
PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND TREATMENT OF CANCER
BR112013030930A2
(pt )
2017-08-08
composições farmacêuticas combinadas para o tratamento de tumores
ZA201502571B
(en )
2019-03-27
Pharmaceutical composition comprising benzyl alcohol for the treatment of migraines
LT2908836T
(lt )
2020-01-27
Farmacinė kompozicija, turinti kurkumino
IL233323B
(en )
2018-11-29
Medical preparations for the treatment of tumors expressing egfr and gm3 n-glycolyl ganglioside (neugcgm3)
EP2902027A4
(en )
2016-06-22
ACTIVE COMPOSITION FOR THE TREATMENT OF TUMORS AND THE USE THEREOF